SE0007100359
SE0007100359
Pandox AB ser. B
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 29.54B EUR | 33.67B EUR | 34.91B EUR | 39.5B EUR |
Enterprise Value | 82.87B EUR | 86.63B EUR | 87.05B EUR | 91.36B EUR |
Valuation Multiples | ||||
Trailing P/E | 9.28x | 13.19x | 11.51x | 15.76x |
Forward P/E | 13.88x | -- | -- | -- |
Price to Sales | 3.73x | 5.66x | 6.16x | 7.19x |
Price to Book | 0.85x | 0.97x | 1x | 1.17x |
EV/Revenue | 10.47x | 14.57x | 15.37x | 16.62x |
EV/EBITDA | 17.26x | 21.6x | 21.45x | 24.53x |
Price to FCF (P/FCF) | 18.87x | -- | -- | -- |
EV/FCF | 52.93x | -- | -- | -- |
FCF Yield | 5.3% | -32.7% | -34.73% | -33.19% |